Waypoint REIT Ltd. WPR

RESTON, Va., June 16, 2026--New presence will support managed hosting and low-latency connectivity to BME Exchange ahead of BME’s planned migration to MD6

NEW YORK, June 01, 2026--Waypoint Bio, an AI-native biotech company using spatial biology to design next-generation CAR T therapies for solid tumors, announced today that it closed a $20M Series A financing round.

Guideway Care, Inc. today announced it has completed the acquisition and integration of Waypoint Healthcare Solutions, LLC to extend Guideway's Enterprise Evidence-Based Patient Activation Intelligence solution and accelerate the creation of a unified architecture for governing execution across the pre- and post-encounter layers of healthcare. Waypoint's entire team, including founders Lisa McDermott and David Bradshaw, has joined the Guideway family.

Waypoint REIT Ltd (ASX:WPR) reports steady rental income growth and strategic buybacks, while addressing market challenges and future opportunities.

In the current global market landscape, small-cap stocks have faced challenges, with the Russell 2000 Index dropping 1.83% amid cautious sentiment and interest rate concerns. Despite these headwinds, opportunities may exist for discerning investors who can identify companies with solid fundamentals and potential for growth in undervalued segments of the market.